Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

Zyn Nicotine Pouches Pulled from Online Shelves: Philip Morris Faces Legal Heat

Daniel Kim Views  

Philip Morris International, a tobacco company, has discontinued the online sale of its popular nicotine pouch brand, Zyn, which is popular among Gen Z and millennials. Philip Morris announced on the 18th that the online sale of Zyn would cease after receiving a subpoena related to banned flavored products in Columbia, the United States. 

The company stated that it would comply with government requests, acknowledging that it could face unspecified material liabilities if adverse outcomes related to this issue occur.

Zyn, a product that delivers nicotine through small pouches similar to teabags placed between the gum and upper lip, has become a key growth driver for Philip Morris. This rise in popularity is particularly notable among Gen Z, who have gravitated towards these tobacco-free pouches. The surging demand has even led to a supply shortage, underscoring the product’s success in the market.

The product has become a popular topic on social media among some conservative influencers, and Tucker Carlson, a former Fox News presenter, has criticized restrictions on Zyn sales.

On the other hand, the product has drawn criticism from lawmakers, including Senate Majority Leader Chuck Schumer, for targeting minors.

Philip Morris secured a distribution network in the United States and new cessation products after investing $16 billion in 2022 to acquire Swedish Match, the manufacturer of Zyn.

Afterward, the company strengthened its marketing for Zyn, and during the first quarter, the shipment of pouches to the United States increased by nearly 80% to 131.6 million units.

Jefferies analyst Owen Bennett said, “A valid question will be how many sales come from other online platforms and independent retailers that are not only selling into DC but also potentially other states/localities that have flavor bans,” noting flavor bans on nicotine and tobacco restrictions across 400 localities and five states.

Philip Morris’s stock fell nearly 3.5% in pre-market trading after analysts raised the possibility that the enforcement action could go beyond DC.

Daniel Kim
content@viewusglobal.com

Comments0

300

Comments0

[LATEST] Latest Stories

  • Pfizer Ends Obesity Drug Trial After Liver Risk Emerges
  • Not Just Old Age: The Pneumonia That Affected Pope Francis’ Final Years
  • China Just Cranked U.S. Tariffs to 84% — And That’s Not the End of It
  • BMW's Next-Gen EV: The Bold New i3 Touring Concept Revealed
  • LEGO Technic Ferrari SF-24 F1 Car: A 1,361-Piece Tribute to Ferrari’s 2024 F1 Season
  • Hyundai’s Ioniq 6 Just Took the Top Spot in J.D. Power’s EV Ownership Study

You May Also Like

  • 1
    Spring’s Secret Weapon for Dry Coughs: Meet Liriope Tea

    LIFESTYLE 

  • 2
    FDA Approves $3.1M Gene Therapy for Rare, Painful Skin Disorder

    LIFESTYLE 

  • 3
    Experts Warn: Toss Your Expired Sunscreen Before It Hurts Your Skin

    LIFESTYLE 

  • 4
    New Drug Helps Patients with Myasthenia Gravis Breathe and Speak Easier

    LIFESTYLE 

  • 5
    Bristol-Myers’ Schizophrenia Drug Falls Short in Key Trial

    LIFESTYLE 

Popular Now

  • 1
    Novavax COVID Vaccine Still on Hold—More Trials Needed, Says FDA

    LIFESTYLE&nbsp

  • 2
    Want to Lower Your Blood Pressure? Eat More Bananas, Study Says

    LIFESTYLE&nbsp

  • 3
    Weekend Workouts Are Enough to Cut Diabetes Risk, Study Says

    LIFESTYLE&nbsp

  • 4
    Brushing Right After Eating Could Hurt Your Teeth—Here’s Why

    LIFESTYLE&nbsp

  • 5
    Early Bedtimes Could Help Teens Boost Brain Power, Study Finds

    LIFESTYLE&nbsp

Must-Reads

  • 1
    Spring’s Secret Weapon for Dry Coughs: Meet Liriope Tea

    LIFESTYLE 

  • 2
    FDA Approves $3.1M Gene Therapy for Rare, Painful Skin Disorder

    LIFESTYLE 

  • 3
    Experts Warn: Toss Your Expired Sunscreen Before It Hurts Your Skin

    LIFESTYLE 

  • 4
    New Drug Helps Patients with Myasthenia Gravis Breathe and Speak Easier

    LIFESTYLE 

  • 5
    Bristol-Myers’ Schizophrenia Drug Falls Short in Key Trial

    LIFESTYLE 

Popular Now

  • 1
    Novavax COVID Vaccine Still on Hold—More Trials Needed, Says FDA

    LIFESTYLE 

  • 2
    Want to Lower Your Blood Pressure? Eat More Bananas, Study Says

    LIFESTYLE 

  • 3
    Weekend Workouts Are Enough to Cut Diabetes Risk, Study Says

    LIFESTYLE 

  • 4
    Brushing Right After Eating Could Hurt Your Teeth—Here’s Why

    LIFESTYLE 

  • 5
    Early Bedtimes Could Help Teens Boost Brain Power, Study Finds

    LIFESTYLE